Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
B.1.506NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.506NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.482NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.482NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.482NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.335NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.335NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.335NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.36.36NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.36.36NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.36.36NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.499.1NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.499.1NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.499.1NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.38NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.38NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.38NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.116NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.116NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.116NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.134NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.134NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.134NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.393NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.393NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.393NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.381NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.381NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.381NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
C.32NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
C.32NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
C.32NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AE.8NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AE.8NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.8NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.516NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.516NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-1906.48Singapore
B.1.1.516NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.1.526NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.1.526NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.1.526NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
B.1.279NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
B.1.279NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
B.1.279NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
AE.7NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
AE.7NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
AE.7NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
N.6NUS-CDC-N-2GCGCGACATTCCGAAGAA1855.562923029213R-21404.2US
N.6NYoung-NAGCACCATAGGGAAGTCC1855.562864828631R-19874.5Singapore
N.6NChan-NGCGTTCTTCGGAATGTCG1855.562921029227F-21207.6China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used